| Class Number |
Class Name |
No. of Patents |
| 930/DIG.532 |
Cyclic peptides derived from at least five amino acids and containing at least one abnormal peptide link (c07k-7/50) |
1 |
| 930/DIG.536 |
With at least one abnormal peptide link in the ring (c07k-7/54) |
7 |
| 930/DIG.537 |
The cyclisation not occurring through the 2,4-diamino-butanoic acid (c07k-7/56) |
3 |
| 930/DIG.538 |
Bacitracins; related peptides (c07k-7/58) |
2 |
| 930/DIG.539 |
With all amino acids in l-form (c07k-7/58a) |
0 |
| 930/DIG.541 |
With at least one amino acid in d-form (c07k-7/58b) |
0 |
| 930/DIG.542 |
The cyclisation occurring through the 4-amino group of the 2,4-diamino butanoic acid (c07k-7/60) |
2 |
| 930/DIG.543 |
Polymyxins; related peptides (c07k-7/62) |
2 |
| 930/DIG.544 |
With all amino acids in l-form (c07k-7/62a) |
0 |
| 930/DIG.545 |
With at least one amino acid in d-form (c07k-7/62b) |
1 |
| 930/DIG.533 |
With only normal peptide links in the ring (c07k-7/52) |
0 |
| 930/DIG.534 |
With all amino acids in l-form (c07k-7/52a) |
2 |
| 930/DIG.535 |
With at least one amino acid in d-form (c07k-7/52b) |
1 |
| 930/DIG.546 |
Cyclic peptides derived from at least five amino acids and containing only normal peptide links (c07k-7/64) |
58 |
| 930/DIG.547 |
Gramicidins s, c; tyrocidins a, b, c; related peptides (c07k-7/66) |
0 |
| 930/DIG.548 |
With all amino acids in l-form (c07k-7/66a) |
15 |
| 930/DIG.549 |
With at least one amino acid in d-form (c07k-7/66b) |
5 |
| 930/DIG.790 |
Linear peptides containing at least one abnormal peptide link and derived from 5-100 amino acids (c07k-7/02) |
6 |
| 930/DIG.800 |
Linear peptides containing only normal peptide links and derived from 5 100 amino acids (c07k-7/04) |
28 |
| 930/DIG.820 |
Contains 21-100 amino acids (c07k-7/10) |
25 |
| 930/DIG.821 |
With all amino acids in l-form (c07k-10a) |
158 |
| 930/DIG.822 |
With at least one amino acid in d-form (c07k-7/10b) |
11 |
| 930/DIG.810 |
Contains only 12-20 amino acids (c07k-7/08) |
10 |
| 930/DIG.811 |
With all amino acids in l-form (c07k-7/08a) |
100 |
| 930/DIG.812 |
With at least one amino acid in d-form (c07k-7/08b) |
3 |
| 930/DIG.801 |
Contains only 5-11 amino acids (c07k-7/06) |
50 |
| 930/DIG.802 |
With all amino acids in l-form (c07k-7/06a) |
178 |
| 930/DIG.803 |
With at least one amino acid in d-form (c07k-06b) |
99 |
| 930/10 |
Peptide or protein sequence |
769 |
| 930/40 |
Angiotensin; related peptides |
60 |
| 930/190 |
Antibiotic |
168 |
| 930/50 |
Atrial or brain natriuretic peptide; related peptides |
40 |
| 930/200 |
Bacterial peptide or bacterial protein (see note 6) |
208 |
| 930/280 |
Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin |
153 |
| 930/60 |
Calcitonin; related peptides |
85 |
| 930/260 |
Containing cys-cys disulfide bridge between nonadjacent cysteine residues (see note 7) |
148 |
| 930/20 |
Containing modified or unusual amino acid (see note 1 and note 2) |
742 |
| 930/21 |
Containing d-amino acid |
754 |
| 930/23 |
Containing halogen (see note 3) |
104 |
| 930/25 |
Containing heavy metal or salt thereof |
13 |
| 930/22 |
Containing radioactive atom (see note 3) |
16 |
| 930/24 |
Containing sulfur (see note 4) |
58 |
| 930/70 |
Corticotropin; related peptides |
32 |
| 930/270 |
Cyclic peptide or cyclic protein (see note 8) |
216 |
| 930/80 |
Endorphin or enkephalin; related peptides |
170 |
| 930/250 |
Enzyme inhibitor |
195 |
| 930/240 |
Enzyme or isoenzyme |
144 |
| 930/90 |
Erythropoietin; related peptides |
14 |
| 930/100 |
Factor viii, ahf; related peptides |
32 |
| 930/110 |
Gonadotropin; related peptides |
43 |
| 930/120 |
Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides |
249 |
| 930/30 |
Linear peptide or protein containing a nonpeptide or abnormal peptide link (see note 5) |
100 |
| 930/31 |
Retro-inverted |
14 |
| 930/310 |
Linker sequence |
31 |
| 930/130 |
Luteinizing hormone-releasing hormone (lh-rh); related peptides |
190 |
| 930/140 |
Lymphokine; related peptides |
55 |
| 930/145 |
Colony stimulating factor |
29 |
| 930/142 |
Interferon |
79 |
| 930/141 |
Interleukin |
88 |
| 930/143 |
Lymphotoxin |
6 |
| 930/144 |
Tumor necrosis factor |
33 |
| 930/320 |
Modification to prevent enzymatic degradation (see note 9) |
13 |
| 930/230 |
Multicellular plant peptide or multicellular plant protein |
22 |
| 930/150 |
Oxytocin or vasopressin; related peptides |
65 |
| 930/210 |
Parasitic peptide or parasitic protein (see note 6) |
34 |
| 930/290 |
Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units |
65 |
| 930/300 |
Signal or leader sequence |
65 |
| 930/160 |
Somatostatin; related peptides |
154 |
| 930/180 |
Thymus derived hormone or factor; related peptides |
63 |
| 930/170 |
Vasoactive intestinal peptides; related peptides |
23 |
| 930/220 |
Viral peptide or viral protein (see note 6) |
86 |
| 930/222 |
Foot and mouth disease related |
11 |
| 930/223 |
Hepatitis related |
35 |
| 930/224 |
Herpes related |
21 |
| 930/221 |
Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related |
75 |
| 930/DIG.500 |
Peptides containing saccharide radicals and having a fully defined sequence of amino acids and wherein the peptide sequence is not part of a ring structure, e.g., bleomycin, phleomycin, muramylpeptides, etc., (c07k-9/00d, 9/00d2, 9/00d4, 9/00d9) |
95 |
| 930/DIG.520 |
Peptides containing saccharide radicals and having a fully defined sequence of amino acids wherein the peptide sequence is part of a ring structure and is not directly attached to a hetero atom of the saccharide atom (c07k-9/00f4) |
1 |
| 930/DIG.510 |
Peptides containing sacchride radicals and having a fully defined sequence of amino acids wherein the peptide sequence is part of a ring structure and is directly attached to a hetero atom of the saccharide atom, e.g., actaplanin, avoparcin, ristomycin, vancomycin, etc., (c07k 9/00f2) |
42 |
| 930/DIG.553 |
Peptides containing the c-terminal sequence (x-cys-phe-gly-phe-gly-gly arg-a-asp-arg-ile-gly-ala-gln-ser-gly-leu-gly-cys-y) with x being nh, y being -oh, nh, or part of the sequence -asn-ser-phe-arg-tyr-arg-arg- and a being met or ile, e.g., atriopeptine; atrial natriuretic peptides and proteins (anp) (c07k-99/00c) |
5 |
| 930/DIG.554 |
With all amino acids in l-form (c07k-99/00c1) |
16 |
| 930/DIG.555 |
With at least one amino acid in d-form (c07k-99/00c2) |
3 |
| 930/DIG.600 |
Peptides containing the sequence (a-arg-pro-pro-gly-phe-ser-pro-phe-arg oh), a being h or lys, e.g., kallidin, bradykinin, etc. or related peptides (c07k-99/18) |
3 |
| 930/DIG.601 |
With all amino acids in l-form (c07k-99/18a) |
2 |
| 930/DIG.602 |
With at least one amino acid in d-form (c07k-99/20) |
0 |
| 930/DIG.590 |
Peptides containing the sequence (a-arg-val-tyr-val- ile- his-pro-phe-b), a being asp or asn, and b being -oh or his-leu-oh, e.g., angiotensin i, pepsitensin, or related peptides (c07k-99/14) |
7 |
| 930/DIG.591 |
With all amino acids in l-form (c07k-99/14a) |
8 |
| 930/DIG.592 |
With at least one amino acid in d-form (c07k-99/16) |
4 |
| 930/DIG.550 |
Peptides containing the sequence (a-leu-glu-ile-lys-orn-ile-phe-his-asp-asp nh2), a being h or ile-cys, e.g., bacitracins a or f or related peptides (c07k-99/00b) |
0 |
| 930/DIG.551 |
With all amino acids in l-form (c07k-99/00b1) |
0 |
| 930/DIG.552 |
With at least one amino acid in d-form (c07k-99/00b2) |
0 |
| 930/DIG.700 |
Peptides containing the sequence (ala-gly-cys-lys-asn-phe-phe- trp lys-thr-phe-thr -ser-cys-oh), e.g., somatostatin, srif, or related peptides (c07k-99/58) |
5 |
| 930/DIG.701 |
All amino acids in l-form (c07k-99/58a) |
37 |
| 930/DIG.702 |
S-s bridge 3,14 being modified (for the reduced form cys-3 or cys-14 being modified) (c07k-99/58a1a) |
7 |
| 930/DIG.705 |
Modification at both cys-3 and cys-14 (c07k-99/58a1d) |
16 |
| 930/DIG.704 |
Modification at cys-14 (c07k-99/58a1c) |
1 |
| 930/DIG.703 |
Modification at cys-3 (c07k-99/58a1b) |
3 |
| 930/DIG.706 |
At least one amino acid in d-form (c07k-99/60) |
37 |
| 930/DIG.707 |
S-s bridge 3,14 being modified (for the reduced form cys-3 or cys-14 being modified) (c07k-99/a1) |
14 |
| 930/DIG.709 |
Modification at cys-14 (c07k-99/60a1c) |
2 |
| 930/DIG.708 |
Modification at cys-3 (c07k-99/60a1b) |
2 |
| 930/DIG.710 |
Modifications at both cys-3 and cys-14 (c07k-99/60a1d) |
29 |
| 930/DIG.750 |
Peptides containing the sequence (arg-lys-asp-val-tyr-val-), e.g., thymin i or ii, thymopoietins, or related peptides (c07k-99/74) |
13 |
| 930/DIG.751 |
With all amino acids in l-form (c07k-99/74a) |
10 |
| 930/DIG.752 |
With at least one amino acid in d-form (c07k-99/76) |
6 |
| 930/DIG.760 |
Peptides containing the sequence (asp-a-gly-pro-tyr-b-met- glu-his phe-arg-trp-gly- ser-pro-pro-lys-asp-oh), a being glu or ser, b being lys or arg, e.g., b-melanotropins or related peptides (c07k-99/78) |
0 |
| 930/DIG.761 |
With all amino acids in l-form (c07k-99/78a) |
0 |
| 930/DIG.762 |
With at least one amino acid in d-form (c07k-99/80) |
0 |
| 930/DIG.556 |
Peptides containing the sequence (asp-pro-a-tyr-b-c-val-ser-asn-ala-asp-leu met-asp- phe-lys-asn-leu-leu-y), with a, b, c being amino acids, and y being a peptide sequence, e.g., cardiodilatin (see subclass 553 for patents that contain the aerial natriuretic peptide sequence) (c07k-99/00d) |
0 |
| 930/DIG.557 |
With all amino acids in l-form (c07k-99/00d1) |
2 |
| 930/DIG.558 |
With at least one amino acid in d-form (c07k-99/00d2) |
0 |
| 930/DIG.580 |
Peptides containing the sequence (ch3co-ser-tyr-ser-met-glu -his-phe arg-trp-gly-lys- pro-val-nh2), e.g., a-msh, or related peptides (fragments which are common with digest 570 are also in that classification) (c07k-99/10) |
0 |
| 930/DIG.581 |
With all amino acids in l-form (c07k-99/10a) |
0 |
| 930/DIG.582 |
With at least one amino acid in d-form (c07k-99/12) |
2 |
| 930/DIG.670 |
Peptides containing the sequence (cys-gly-asn-leu-ser-thr-cys -met leu-gly-thr-tyr- thr-glu-asp-phe-asn-lys -phe-his-thr-phe-pro -gln thr-ala-ile-gly- val-gly-ala-pro-oh), e.g., calcitonin m (human) or related peptides (fragments which are common with digest 660 are also in that classification) (c07k-99/46) |
17 |
| 930/DIG.671 |
With all amino acids in l-form (c07k-99/46a) |
16 |
| 930/DIG.672 |
With at least one amino acid in d-form (c07k-99/48) |
3 |
| 930/DIG.565 |
Peptides containing the sequence (cys-tyr-a-gln-asn-cys-pro-b -gly nh2), with a being ile or phe, b being leu or arg or lys or s-s bridge 1-6, e.g., oxytocin, vasopressin, or a related peptide (c07k 99/02) |
17 |
| 930/DIG.566 |
With all amino acids in l-form (c07k-99/02a) |
25 |
| 930/DIG.567 |
With at least one amino acid in d-form (c07k-99/04) |
29 |
| 930/DIG.620 |
Peptides containing the sequence (gly-ile-val-glu-gln-cys-cys -a-b-c cys-ser-leu-tyr-gln -leu-glu-asn-tyr-cys -asn-ph) and (phe-val-asn- gln-his-leu-cys-gly-ser- his-leu-val-glu-ala-leu- tyr-leu-val-cys gly-glu- arg-gly-phe -phe-tyr-tyr-pro-lys-d), a-b-c being -ala-ser val-, or -ala-gly-val-, or -thr-ser-ile-, or -ala-ser-val-, d being ala-oh or thr-oh, e.g., human insulin or related peptides (c07k-99/26) |
24 |
| 930/DIG.621 |
With all amino acids in l-form (c07k-99/26a) |
21 |
| 930/DIG.622 |
With at least one amino acid in d-form (c07k-99/28) |
3 |
| 930/DIG.680 |
Peptides containing the sequence (hco-val- ile- gly-ala-leu-ala-val val- val-trp-leu-trp- phe- leu-trp-leu-trp-nhch2ch2oh), e.g., gramicidins a or b or related peptides (c07k-99/50) |
0 |
| 930/DIG.681 |
With all amino acids in l-form (c07k-99/50a) |
0 |
| 930/DIG.682 |
With at least one amino acid in d-form (c07k-99/52) |
0 |
| 930/DIG.650 |
Peptides containing the sequence (his-ser-asp-gly-thr-phe-thr -ser glu-leu-ser-arg-leu-arg -asp-ser-ala-arg-leu-gln-arg -leu-leu-gln gly-leu-val-nh2), e.g., secretin or related peptides, etc. (fragments containing the unchanged sequence 4-8, i.e., gly-thr-phe-thr-ser are also classified in digest 640) (c07k-99/38) |
3 |
| 930/DIG.651 |
With all amino acids in l-form (c07k-99/38a) |
6 |
| 930/DIG.652 |
With at least one amino acid in d-form (c07k-99/40) |
0 |
| 930/DIG.640 |
Peptides containing the sequence (his-ser-gln-gly-thr-phe-thr -ser asp-tyr-lys-ser- tyr-leu-asp-ser-arg-arg-ala -gln-asp-phe-val-gln-trp leu- met-asn-thr-oh), e.g., glucagon or related peptides, etc. (c07k-99/34) |
5 |
| 930/DIG.641 |
With all amino acids in l-form (c07k-99/34a) |
4 |
| 930/DIG.642 |
With at least one amino acid in d-form (c07k-99/36) |
0 |
| 930/DIG.630 |
Peptides containing the sequence (pgl-gly-pro-trp-a-glu-glu- b-glu-b ala-tyr- gly-trp-met- leu- asp-phe- tyr- nh2, a being met, leu or val, b being glu or ala, e.g., gastrin or related peptides, etc. (c07k 99/30) |
9 |
| 930/DIG.631 |
With all amino acids in l-form (c07k-99/30a) |
10 |
| 930/DIG.632 |
With at least one amino acid in d-form (c07k-99/32) |
2 |
| 930/DIG.690 |
Peptides containing the sequence (pgl-his-trp-ser-tyr-gly-leu -arg pro-gly-nh2), e.g., lh-rh, lrf, or related peptides (c07k-99/54) |
9 |
| 930/DIG.691 |
With all amino acids in l-form (c07k-99/54a) |
26 |
| 930/DIG.692 |
1-pgl, 10-gly derivatives (c07k-99/54a1) |
2 |
| 930/DIG.693 |
Des-1-pgl derivatives (c07k-99/54a2) |
3 |
| 930/DIG.694 |
Des-10-gly derivatives (c07k-99/54a3) |
15 |
| 930/DIG.695 |
With at least one amino acid in d-form (c07k-99/56) |
34 |
| 930/DIG.696 |
1-pgl, 10-gly derivatives (c07k-99/56a1) |
10 |
| 930/DIG.697 |
Des-1-pgl derivatives (c07k-99/56a2) |
16 |
| 930/DIG.698 |
Des-10-gly derivatives (c07k-99/56a3) |
51 |
| 930/DIG.610 |
Peptides containing the sequence (pgl-pro-ser-lys-asp-ala-phe -ile gly-leu-met-nh2), e.g., eledoisin, or related peptides (c07k-99/22) |
0 |
| 930/DIG.611 |
With all amino acids in l-form (c07k-99/22a) |
0 |
| 930/DIG.612 |
With at least one amino acid in d-form (c07k-99/24) |
0 |
| 930/DIG.570 |
Peptides containing the sequence (ser-tyr-ser-met-glu-his-phe -arg trp-gly-lys-pro-val-gly -lys-lys-arg-arg-pro-val-lys -val-tyr-pro asp-gly- a-b-c-d-e-ala-glu- ala-phe-pro-leu-glu-phe-oh), a-b-c-d-e being glu-ala-glu-asp-ser- or ala-glu-asp-glu-leu or ala-glu-asp-glu-ser, e.g., corticotropin (acth) or related peptides (c07k-99/06) |
6 |
| 930/DIG.571 |
With all amino acids in l-form (c07k-99/06a) |
16 |
| 930/DIG.572 |
With at least one amino acid in d-form (c07k-99/08) |
12 |
| 930/DIG.770 |
Peptides containing the sequence (thr-val-pro-ser- (n-methyl)val-) (c07k-99/82) |
0 |
| 930/DIG.771 |
With all amino acids in l-form (c07k-99/82a) |
0 |
| 930/DIG.772 |
With at least one amino acid in d-form (c07k-99/84) |
0 |
| 930/DIG.740 |
Peptides containing the sequence (try-gly-gly-phe-x), x being an amino acid, e.g., enkephalins or related peptides (sequences containing more than five amino acids are classified in digests 720 or 730) (c07k 99/70) |
16 |
| 930/DIG.741 |
With all amino acids in l-form (c07k-99/70a) |
17 |
| 930/DIG.742 |
With at least one amino acid in d-form (c07k-99/72) |
39 |
| 930/DIG.559 |
Peptides containing the sequence (tyr-ala-asp-ala-ile-phe-tyr -asn-ser tyr-arg-lys-val -leu-gly-gln-leu-ser- ala-arg-lys-leu-leu- gln-asp ile-met-a-arg- gln-gln-gly-glu-b-asn- gln-glu-c-gly- -ala-d-e arg-leu-nh) with a being ser or asn, b being ser or arg, c being arg or gln, d being arg or lys, and e being ala, val, or phe, e.g., somatoliberin (gonadotropin releasing factor) (c07k-99/00f) |
21 |
| 930/DIG.560 |
Peptides containing the sequence (tyr-d-ala-phe-gly-tyr -pro-ser), e.g., dermorphin (c07k-99/00h) |
0 |
| 930/DIG.730 |
Peptides containing the sequence (tyr-gly-gly-phe-met-thr-ser- glu lys-ser-gln- thr-pro-leu-val-thr-oh), e.g., lipotropin or related peptides (fragments which are common with digest 720 are also in that classification) (c07k-99/66) |
5 |
| 930/DIG.731 |
With all amino acids in l-form (c07k-99/66a) |
17 |
| 930/DIG.732 |
With at least one amino acid in d-form (c07k-99/68) |
21 |
| 930/DIG.720 |
Peptides containing the sequence (tyr-gly-gly-phe-met-thr-ser- glu lys-ser-gln-thr-pro- leu-val-thr-leu-phe-lys-asn- ala-ile-ile-lys-asn ala-his- lys-lys-gly-glu-oh), e.g., b-endorphin or related peptides (c07k-99/62) |
6 |
| 930/DIG.721 |
With all amino acids in l-form (c07k-99/62a) |
13 |
| 930/DIG.722 |
With at least one amino acid in d-form (c07k-99/64) |
22 |
| 930/DIG.660 |
Peptides containing the squence (cys-ser-asn-leu-ser-thr-cys -val leu-ser-ala-tyr-trp-arg -asn-leu-asn-asn-phe-his -arg-phe-ser-gly-met gly- phe-gly-pro-glu-thr-pro-oh), e.g., a-thyrocalcitonin, etc., i.e., porcine or related peptides (c07k-99/42) |
18 |
| 930/DIG.661 |
With all amino acids in l-form (c07k-99/42a) |
26 |
| 930/DIG.662 |
With at least one amino acid in d-form (c07k-99/44) |
3 |
| 930/DIG.530 |
Proteins having a fully defined sequence of amino acids or derivatives thereof, i.e., more than 100 amino acids (c07k-13/00) |
31 |
| 930/DIG.780 |
Tetrapeptides (derived from only four amino acids) (c07k-5/10) |
5 |
| 930/DIG.781 |
Contains at least one ring formed only through peptide links (c07k 5/12b) |
3 |
| 930/DIG.783 |
The first amino acid being heterocyclic (pro) (c07k-5/10h) |
49 |
| 930/DIG.787 |
The first amino acid contains more amino groups than carboxylic acid or derivative groups (basic) (c07k-5/10b) |
36 |
| 930/DIG.788 |
The first amino acid contains more carboxylic acid or derivative groups than amino groups (acidic) (c07k-5/10c) |
22 |
| 930/DIG.789 |
Asp-x-y-z, asn-x-y-z, or derivatives thereof, x, y and z being amino acids (c07k-5/10c1) |
0 |
| 930/DIG.784 |
The first amino acid contains the same number of amino and carboxylic acid or derivative groups (neutral) (c07k-5/10a) |
1 |
| 930/DIG.785 |
And aliphatic (c07k-5/10a1) |
122 |
| 930/DIG.786 |
And carbocyclic ring (phe) (c07k-5/10a2) |
30 |
| 930/DIG.782 |
With at least one amino acid in d-form (c07k-5/10z) |
93 |
